Commercially Available Blocking Oligonucleotides Effectively Suppress Unwanted Hemolysis-Related miRNAs in a Large Whole-Blood RNA Cohort
- 1 June 2021
- journal article
- research article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 23 (6) , 671-682
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01HL125583, R01 HL127332, R01 HL129935, R01HL130512, R01HL139634, U01 HL089856, U01 HL089897)
This publication has 27 references indexed in Scilit:
- Technical Factors Involved in the Measurement of Circulating MicroRNA Biomarkers for the Detection of Colorectal NeoplasiaPLOS ONE, 2014
- Variation in RNA-Seq Transcriptome Profiles of Peripheral Whole Blood from Healthy Individuals with and without Globin DepletionPLOS ONE, 2014
- The Impact of Hemolysis on Cell-Free microRNA BiomarkersFrontiers in Genetics, 2013
- Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker StudiesCancer Prevention Research, 2012
- Haemolysis during Sample Preparation Alters microRNA Content of PlasmaPLOS ONE, 2011
- RNA-ligase-dependent biases in miRNA representation in deep-sequenced small RNA cDNA librariesRNA, 2011
- Efficient microRNA capture and bar-coding via enzymatic oligonucleotide adenylationNature Methods, 2008
- E2F1-Regulated MicroRNAs Impair TGFβ-Dependent Cell-Cycle Arrest and Apoptosis in Gastric CancerCancer Cell, 2008
- Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTRProceedings of the National Academy of Sciences, 2007
- Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA TargetsCell, 2005